BioTuesdays

Tag - VIVE

Markets

AGP starts Viveve Medical at buy; PT $10.75

Alliance Global Partners launched coverage of Viveve Medical (NASDAQ:VIVE) with a “buy” rating and price target of $10.75. The stock closed at $3.55 on Jan. 28. “After two disappointing, yet entirely explainable...

January 29, 2021
Viveve Medical Logo
Markets

Stifel cuts Viveve Medical to hold; PT to $1 from $3

Stifel downgraded Viveve Medical (NASDAQ:VIVE) to “hold” from “buy” and lowered its price target to $1 from $3 after the company’s LIBERATE-International trial for stress urinary incontinence (SUI) missed its primary...

July 23, 2019
Viveve Medical Logo
Markets

Stifel starts Viveve Medical at buy; PT $6

Stifel launched coverage of Viveve Medical (NASDAQ:VIVE) with a “buy” rating and $6 price target. The stock closed at $3.36 on April 16. Viveve is focused on development and marketing the Viveve system and the Geneveve...

April 16, 2018